Recently, we discovered a novel class of natural products, named the triden
tatols, in a marine hydroid. Close examination of their molecular structure
s suggested that they may have antioxidant activity. This observation promp
ted us to evaluate in vitro the capacity of one of these tridentatols, viz.
tridentatol A, to inhibit lipid peroxidation using human low density lipop
rotein (LDL) as an experimental model. LDL was incubated with 5 mu M cupric
chloride (Cu2+) in the absence and presence of tridentatol A or a referenc
e antioxidant standard, i.e. vitamin E. The onset of rapid formation of con
jugated lipid hydroperoxides was delayed in a concentration-dependent manne
r by tridentatol A. More specifically, LDL incubated with Cu2+ had a lag-ph
ase time (the elapsed time before the onset of rapid formation of conjugate
d lipid hydroperoxides) of 150 min. However, when 0.5 mu M tridentatol A wa
s present during incubation, the lag phase time was extended to 225 min. Wi
th 1 mu M tridentatol A, the lag phase time was 300 min. The same concentra
tions of vitamin E produced noticeably lower lag phase times. Thus, compare
d with vitamin E, tridentatol A better protected against the formation of c
onjugated lipid hydroperoxides in LDL. Direct colorimetric measurements of
both lipid hydroperoxides and thiobarbituric acid-reactive substances confi
rmed the greater potency of tridentatol A relative to vitamin E. Furthermor
e, tridentatol A negated the Cu2+ induced increase in electrophoretic mobil
ity of LDL to a greater extent than vitamin E. In conclusion, tridentatol A
is a powerful antioxidant against lipid peroxidation of LDL and is signifi
cantly more potent than vitamin E in this regard. (C) 1999 Elsevier Science
Inc.